The top 250 cancer specialists converge in Belgium to push the frontiers of proton therapy
IBA hosted its Proteus User Meeting 2026 in Belgium, gathering over 250 cancer specialists to discuss advancements in proton therapy. The event marked 25 years since the first patient was treated with a Proteus system at Mass General Brigham Cancer Center.
IBA, the world leader in particle accelerator technology, hosted its Proteus User Meeting 2026 in Louvain-La-Neuve, Belgium. Over 250 oncologists, physicists, and clinicians from prestigious cancer care institutions worldwide attended the event. The three-day meeting focused on improving cancer patient outcomes through scientific exchange, covering topics such as patient selection strategies and hardware innovation. The event celebrated 25 years of Proteus system treatments and IBA's 40 years of innovation in cancer care technology. Mass General Brigham Cancer Center, where the first Proteus system treatment took place, co-hosted the event. Participants engaged in plenary sessions, technical workshops, and networking sessions to advance proton therapy.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.